# Octane Medical Group

Octane Medical Group is an Asset Manager based in Kingston, Canada.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Kingston, Canada
- **Region:** North America
- **Address:** 369 Dalton Ave, Kingston, Ontario, K7K 6Z1, Canada
- **Assets under management:** Undisclosed
- **Website:** octaneco.com

## Regulatory record

- **Reports private funds:** No

## About

Octane Medical Group is a global medical technology company headquartered in Canada with locations in the United States and Europe. It develops advanced bioprocesses, biomaterials and bioreactors for regenerative medicine. The firm innovates medical technologies, advances them into production within market-specific ventures, and builds partnerships for global commercialization, with the goal of making regenerative medicine the standard of care.

## Sectors

- Regenerative Medicine
- BioTech
- Medical Devices

## Offices

- United States
- Europe

## Questions

### What is the Cocoon platform, and why does it matter for Octane’s structure?

The Cocoon platform is Octane’s proprietary automated bioreactor system for cell therapy manufacturing. It functions as both a licensable technology — Octane partners with firms like Lonza to deploy Cocoon production systems — and an internal production backbone for Octane’s own ventures, such as Octane Biotherapeutics. This dual-use design lets the group generate partnership revenue while retaining the manufacturing capability to scale its own cell therapy products, a configuration rare among pure-play CDMOs or biotech startups.

### How did Octane build its orthobiologics and CDMO businesses so quickly?

Octane acquired them. In June 2024, the group bought B. Braun’s global orthobiologics business, which brought TETEC AG in Germany and Aesculap Biologics in the United States under Octane’s control (per the firm, June 2024). In March 2026, it signed an agreement to acquire Lonza’s Personalized Medicine business, adding a full-scale cell therapy CDMO operation (per the firm, March 2026). Rather than building from scratch, Octane used acquisitions to instantly gain commercial-scale manufacturing and distribution in orthobiologics and personalized medicine.

## Related profiles

- [O'Connor Financial Group](https://altss.com/profile/oconnor-financial-group)
- [Octavia Investments](https://altss.com/profile/octavia-investments-llc)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/octane-medical-group

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology